KBP-7072

DRUG4 trials

Sponsors

KBP Biosciences

Conditions

HealthyHealthy Subjects

Phase 1

Safety, Tolerability and Pharmacokinetics of KBP-7072

CompletedNCT02454361

KBP BiosciencesHealthy

Start: 2015-05-31End: 2015-12-31Updated: 2024-02-23

A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects

CompletedNCT02654626

KBP BiosciencesHealthy

Start: 2015-10-31End: 2015-12-31Updated: 2024-02-23

A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects

CompletedNCT04532957

KBP BiosciencesHealthy

Start: 2020-08-11End: 2020-10-15Updated: 2024-02-23

Study of KBP-7072 in Healthy Male and Female Subjects

CompletedNCT05507463

KBP BiosciencesHealthy Subjects

Start: 2022-08-16End: 2023-06-29Updated: 2024-02-23

Related Papers

<i>In Vitro</i> Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates

Antimicrobial Agents and Chemotherapy2020-02-1228 citations